Navigation Links
Regado Biosciences Announces First Patient Enrolled in RADAR (Phase 2b) Study of REG1 Anticoagulation System
Date:9/9/2009

BASKING RIDGE, N.J., Sept. 9 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, announced that on September 8, 2009 enrollment of the first patient in a Phase 2b, randomized, partially-blinded, multi-center, active-controlled, dose-ranging study of its lead product candidate, the REG1 anticoagulation system (REG1) was achieved. REG1 comprises the selective factor IXa inhibitor, RB006, and its specific active control agent, RB007. The trial, called RADAR, will assess the safety, efficacy, and pharmacodynamics of REG1 compared to unfractionated heparin or low molecular weight heparin in subjects with acute coronary syndromes (ACS). Regado recently successfully completed a phase 2a study of REG1 in stable coronary artery disease patients undergoing elective PCI.

The primary objectives of RADAR will be to determine the clinically acceptable dose range of the specific active control agent, RB007, which can be used to reliably partially or totally reverse the anticoagulant effect of RB006 while reducing bleeding in comparison to heparin, and to determine the pharmacodynamics of the REG1 anticoagulation system in subjects intended for cardiac catheterization within 24 hours who are admitted for ACS-unstable angina and myocardial infarction without ST-segment elevation (UA/NSTEMI).

RADAR, led by principal investigator John H. Alexander, MD, MHS, FACC of Duke University, will enroll 800 subjects at approximately 75 centers around the world. Participating countries include USA, Canada, Poland, France, Germany, Netherlands and Belgium. More information about RADAR can be found at www.clinicaltrials.gov. The identifier for this trial is NCT00932100.

"We are very excited to report the first patient being en
'/>"/>

SOURCE Regado Biosciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Regado Biosciences to Present at 19th Annual Piper Jaffray Health Care Conference
2. Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality Assurance
3. Regado Biosciences to Present at the 2009 Wharton Healthcare Business Conference
4. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
5. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
6. Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
7. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
8. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
9. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
10. Anaptys Biosciences Raises Over $33 Million in Series B Financing
11. YM BIOSCIENCES REPORTS FIRST QUARTER 2008 OPERATIONAL AND FINANCIAL RESULTS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Joseph M. Lee, M.D., M.S., R.P.V.I, ... a leading provider of quality cardiovascular and internal medicine ... Dr. Lee is a board certified cardiologist with a ... addition to his position at CDHV, Dr. Lee is ... Columbia University Medical Center. Dr. Lee is board certified ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Women in ... take charge of their financial future. The Independent ... has opened registration for 6 upcoming Los Angeles area ... for women, and with input from Kim Kiyosaki, a ... It’s Rising Time) who is passionate about women’s financial ...
(Date:7/31/2014)... steadily in the U.S in recent years. According to ... number of individuals reporting past year heroin use almost ... suggests the increase may be linked to prescription opioid ... use to heroin use, with POs providing the entryway ... This drug-use trajectory appears to have become increasingly common ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Clifton Dental ... the application of topical fluoride treatments to their adult ... and help with tooth sensitivity in patients that exhibit ... an infection that is commonly known as “tooth decay” ... tissues of the teeth. , Fluoride therapy ...
(Date:7/31/2014)... Reinberg HealthDay Reporter THURSDAY, ... rather than war experiences, are a source of drinking problems ... study suggests. Setbacks such as job loss, divorce and ... make as many as 13 percent of vets turn to ... has an important effect on mental health in the short ...
Breaking Medicine News(10 mins):Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 2Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 3Health News:The Independent Woman to Offer Financial Workshops in the Los Angeles Area - Developed by Women for Women 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 3Health News:NJ Top Dentists Approved, Clifton Dental Associates Now Actively Recommending the Application of Topical Fluoride Treatments to Adults 2Health News:Civilian Life, Not Combat, May Drive Many Veterans to Drink 2Health News:Civilian Life, Not Combat, May Drive Many Veterans to Drink 3
... Americans with muscular dystrophy die 10 to 12 years younger ... Sept. 14 issue of Neurology , the medical journal ... gap, which was calculated on the basis of 20 years ... annals of research into racial disparities in health care, say ...
... Colorado at Boulder study sheds light on the brain mechanisms ... helpful in improving treatments for the millions of people who ... study, CU-Boulder psychology Professor Yuko Munakata and her research colleagues ... nerve cell suppresses activity in another, is a critical aspect ...
... National Hispanic Science Network on Drug Abuse awarded the ... Investigator to Alice Cepeda, sociology professor and associate director ... Graduate College of Social Work, University of Houston. ... annual conference in New Orleans. , The National ...
... By Jenifer Goodwin HealthDay Reporter , MONDAY, ... levels of thimerosal, a mercury-laden preservative that used to be ... autism than infants exposed to only a little thimerosal, new ... who worry that vaccination raises their children,s risk for autism, ...
... 13 (HealthDay News) -- Women can be vulnerable to ... part of a condition called preeclampsia. And now ... which women are most prone to preeclampsia in late ... relies on so-called "metabolic profiling" to track telltale metabolites ...
... mental aging reveals a good news-bad news situation. The bad ... to varying degrees. The good news is the drops are ... study published by the American Psychological Association. "There ... called crystallized intelligence decline at older ages," said study author ...
Cached Medicine News:Health News:Blacks with muscular dystrophy die 10-12 years younger than whites: New study 2Health News:CU-Boulder study sheds light on how our brains get tripped up when we're anxious 2Health News:CU-Boulder study sheds light on how our brains get tripped up when we're anxious 3Health News:University of Houston researcher receives National Award of Excellence in Research 2Health News:More Evidence That Vaccines Don't Cause Autism 2Health News:More Evidence That Vaccines Don't Cause Autism 3Health News:Test Might Spot Women at High Risk for Pregnancy Complication 2Health News:Test Might Spot Women at High Risk for Pregnancy Complication 3Health News:New study reconciles conflicting data on mental aging 2Health News:New study reconciles conflicting data on mental aging 3
(Date:7/31/2014)... YORK and VIENNA , July ... at a press conference in New York ... PD01A, a vaccine against Parkinson,s disease. PD01A is the first ... to enter clinical testing. The Michael J. Fox ... $ 1.5 million grant, and presented at the press conference ...
(Date:7/31/2014)... AUSTIN, Texas , July 31, 2014 Vermillion, ... cancers and women,s health, will hold a conference call on ... discuss results for the second quarter ended June 30, 2014. ... to the call. Vermillion,s Chairman, President and CEO ... a question and answer period. Date: Thursday, August ...
(Date:7/31/2014)... July 31, 2014 The Galien Foundation today ... Galien USA Awards. The Prix ... and recognizes the technical, scientific and clinical research skills ... This year brings the highest number of nominees since ... . Nominees include biomedical products across three categories ...
Breaking Medicine Technology:First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5
... HEIGHTS, Ill., Nov. 1, 2011 When it comes to ... and determine the best course of treatment depends on the ... Palos Community Hospital offers patients the most advanced technology in ... is one of only two PEM scanners in the Chicagoland ...
... 1, 2011 Custom Spine unveils its new auxiliary connector ... an extension to the company,s ISSYS LP pedicle screw system, ... screw to be fully seated while maintaining full polyaxial motion ... is unique in its ability to accept multiple rod sizes ...
Cached Medicine Technology:Palos Offers New Technology in the Fight Against Breast Cancer 2Custom Spine Features Unique Auxiliary Connector System at NASS 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: